Noesis Capital Mangement’s AstraZeneca AZN Stock Holding History

Noesis Capital Mangement’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,517	Closed	-$463K	–	127
2025 Q4	$463K	Buy	2,517 +12	+0.5%	+$2.1K	0.07%	77
2025 Q3	$384K	Hold	2,505	–	–	0.06%	81
2025 Q2	$350K	Hold	2,505	–	–	0.06%	85
2025 Q1	$368K	Hold	2,505	–	–	0.07%	84
2024 Q4	$328K	Hold	2,505	–	–	0.06%	85
2024 Q3	$390K	Hold	2,505	–	–	0.08%	80
2024 Q2	$391K	Hold	2,505	–	–	0.09%	73
2024 Q1	$339K	Hold	2,505	–	–	0.08%	74
2023 Q4	$337K	Sell	2,505 -500	-17%	-$65K	0.08%	74
2023 Q3	$407K	Hold	3,005	–	–	0.11%	69
2023 Q2	$430K	Hold	3,005	–	–	0.11%	70
2023 Q1	$417K	Sell	3,005 -58	-2%	-$7.8K	0.11%	67
2022 Q4	$415K	Hold	3,063	–	–	0.12%	64
2022 Q3	$336K	Buy	3,063 +58	+2%	+$7.36K	0.1%	70
2022 Q2	$397K	Sell	3,005 -60	-2%	-$7.87K	0.12%	66
2022 Q1	$407K	Hold	3,065	–	–	0.1%	69
2021 Q4	$357K	Buy	3,065 +60	+2%	+$7.06K	0.07%	85
2021 Q3	$361K	Hold	3,005	–	–	0.07%	84
2021 Q2	$341K	Hold	3,005	–	–	0.07%	81
2021 Q1	$299K	Hold	3,005	–	–	0.07%	88
2020 Q4	$300K	Hold	3,005	–	–	0.07%	79
2020 Q3	$329K	Hold	3,005	–	–	0.09%	71
2020 Q2	$318K	Hold	3,005	–	–	0.1%	77
2020 Q1	$268K	Hold	3,005	–	–	0.1%	79
2019 Q4	$300K	Buy	+3,005	New	+$283K	0.08%	91

Other funds holding AZN

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Asset Management London, Ec4n 8af $148B AUM

Noesis Capital Mangement's AZN Position: Q1 2026 in Review

Noesis Capital Mangement sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 2,517 shares — an estimated $463K sold.

Noesis Capital Mangement first reported a position in AZN in Q4 2019 and held it in 25 quarters. The position peaked at $463K in Q4 2025. 1,383 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Noesis Capital Mangement reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
Noesis Capital Mangement sold 2,517 AstraZeneca shares in Q1 2026, an estimated $463K.
Noesis Capital Mangement first reported a position in AstraZeneca in Q4 2019 and held it in 25 quarters.
Noesis Capital Mangement's AstraZeneca position peaked at $463K in Q4 2025.
1,383 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Noesis Capital Mangement's 13F filing for Q1 2026, filed 5 May 2026.